相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Performance of DAXX Immunohistochemistry as a Screen for DAXX Mutations in Pancreatic Neuroendocrine Tumors
Jaclyn F. Hechtman et al.
PANCREAS (2019)
DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors
Joo Kyung Park et al.
ONCOTARGET (2017)
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas
Laura H. Tang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applications
Iris H. Liu et al.
CANCER TREATMENT REVIEWS (2016)
Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact
Brandon J. Manley et al.
CURRENT OPINION IN UROLOGY (2016)
Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis
Aga Syed Sameer et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2014)
Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
Stephan E. Baldus et al.
CLINICAL CANCER RESEARCH (2010)
Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres
Peter W. Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
T. R. Halfdanarson et al.
ANNALS OF ONCOLOGY (2008)
Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system
Christian N. Arnold et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Is the new classification of neuroendocrine pancreatic tumors of clinical help?
M Schindl et al.
WORLD JOURNAL OF SURGERY (2000)